2013
DOI: 10.1177/2045125313512325
|View full text |Cite
|
Sign up to set email alerts
|

Ivabradine, a novel treatment for clozapine-induced sinus tachycardia: a case series

Abstract: This is the first report in the literature demonstrating that ivabradine appears to be a well tolerated agent, which should be considered as a symptomatic treatment of clozapine-induced tachycardia if the use of a β blocker fails due to a lack of response or intolerability.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
15
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
5
1
1

Relationship

1
6

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 43 publications
0
15
0
Order By: Relevance
“…Other potential causes, such as myocarditis, cardiomyopathy, or neuroleptic malignant syndrome were ruled out since the absence of the symptoms with normal cardiac markers and rapid resolve of tachycardia following clozapine cessation. 8,9 In contrast to this case, most of the previously-reported ones presented with tachycardia at clozapine doses over 50 mg. [10][11][12][13][14][15] The only exception, 37.5 mg/day, still greatly exceeded the dose described here. 16 Furthermore, the onset of tachycardia in those cases ranged from five days to two months after clozapine initiation, much longer than two days observed in this case.…”
Section: Discussionmentioning
confidence: 79%
See 2 more Smart Citations
“…Other potential causes, such as myocarditis, cardiomyopathy, or neuroleptic malignant syndrome were ruled out since the absence of the symptoms with normal cardiac markers and rapid resolve of tachycardia following clozapine cessation. 8,9 In contrast to this case, most of the previously-reported ones presented with tachycardia at clozapine doses over 50 mg. [10][11][12][13][14][15] The only exception, 37.5 mg/day, still greatly exceeded the dose described here. 16 Furthermore, the onset of tachycardia in those cases ranged from five days to two months after clozapine initiation, much longer than two days observed in this case.…”
Section: Discussionmentioning
confidence: 79%
“…Only a few presented with SVT and these were mainly dose-dependent and involved rapid titration. [10][11][12][13][14][15][16] However, in this case, SVT developed early (two days) after a low dose of clozapine (25 mg) was slowly titrated.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…According to our own experience, β-blockers for example, low doses of bisoprolol, are well tolerated and β-block addon may also offer symptomatic relief in patients who are aware of and suffer from tachycardia. However, clozapine often causes orthostatic reactions and in the case of hypotension or orthostatism, ivabradine may be a better option (Lally et al, 2014). A liberal use of Therapeutic Drug Monitoring with controls of serum clozapine levels is strongly recommended as our data suggest a dose-response relationship for tachycardia.…”
Section: Discussionmentioning
confidence: 97%
“…If confirmed as a benign sinus tachycardia, then slowing the rate of titration may help. Beta‐blockers or ivabradine may be necessary if persistent .…”
Section: Methodsmentioning
confidence: 99%